10 Biggest Biotechnology Companies

The biotechnology trade is comprised of a whole bunch of firms that fuse biology and expertise to develop medicine and associated merchandise for the remedy of illnesses and medical circumstances. As we speak’s biotechnology trade consists of firms that make medical units and diagnostics, biofuels, biomaterials, air pollution controls, and extra.

Among the many largest firms within the trade are pharmaceutical firms like Novo Nordisk and Moderna. These firms typically give attention to creating and testing new drug compounds for medical use and should undergo prolonged trial and approval processes for his or her merchandise. This implies traders typically should wait months and even years earlier than figuring out whether or not a possible drug remedy is usable or worthwhile.

Regardless of the numerous challenges dealing with biotechnology firms, a number of enterprises have risen to the highest of the record. Beneath, we have a look at the ten greatest as measured by 12-month trailing (TTM) income. This record is proscribed to publicly traded firms within the U.S. or Canada, both instantly or by ADRs. Some international firms might report semiannually and will have longer lag instances. All figures are as of Dec. 20, 2022, and all knowledge is supplied by YCharts.

• Income (TTM): $24.31 billion
• Web Revenue (TTM): $7.68 billion
• Market Cap: $293.94 billion
• 1-Yr Trailing Whole Return: 23.38%
• Change: New York Inventory Change

Novo Nordisk is a multinational biotech firm headquartered in Denmark with manufacturing amenities in seven international locations and associates or workplaces in 16 international locations. The corporate’s major focus is diabetes care, hemophilia care, progress hormone remedy, and hormone substitute remedy. The corporate makes a number of medicine below varied model names, together with Levemir, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza.

• Income (TTM): $20.68 billion
• Web Revenue (TTM): $11.76 billion
• Market Cap: $72.95 billion
• 1-Yr Trailing Whole Return: -35.59%
• Change: Nasdaq

Moderna is headquartered in Cambridge, MA. It turned included in 2010, making it one of many youngest biotech corporations on the record. The corporate develops medicines primarily based on messenger ribonucleic acids (mRNA), a single-strand molecule that makes life-sustaining proteins. Moderna made headlines after growing an mRNA-based COVID-19 vaccine in 2020.

Moderna focuses its mRNA medicines on autoimmune problems, uncommon and infectious illnesses, and immuno-oncology.

• Income (TTM): $20.37 billion
• Web Revenue (TTM): $11.35 billion
• Market Cap: $40.91 billion
• 1-Yr Trailing Whole Return: -40.54%
• Change: Nasdaq

BioNTech is headquartered in Mainz, Germany. It was based in 2008 by Ugur Sahin and Ozlem Turci, a husband and spouse workforce who desired to tailor most cancers remedies for particular person sufferers. In 2020, it partnered with Pfizer to develop the primary COVID-19 vaccine.

• Income (TTM): $13.71 billion
• Web Revenue (TTM): $5.37 billion
• Market Cap: $78.53 billion
• 1-Yr Trailing Whole Return: 16.44%
• Change: Nasdaq

Biopharmaceutical firm Regeneron develops and markets drug remedies for sufferers with eye illness, most cancers, cardiovascular illnesses, allergic and inflammatory points, and infectious illnesses. The corporate goals to conduct one of many largest gene sequencing operations worldwide by its Regeneron Genetics Heart.

• Income (TTM): $8.7 billion
• Web Revenue (TTM): $3.27 billion
• Market Cap: $74.85 billion
• 1-Yr Trailing Whole Return: 35.91%
• Change: Nasdaq

Biopharmaceutical firm Vertex focuses on creating and advertising drug remedies for sufferers with most cancers, cystic fibrosis, autoimmune illnesses, neurological problems and others.

• Income (TTM): $3.58 billion
• Web Revenue (TTM): -$18.69 million
• Market Cap: $9.85 billion
• 1-Yr Trailing Whole Return: 24.81%
• Change: Nasdaq

Irish biopharmaceutical firm Jazz Prescription drugs creates and commercializes drug merchandise designed to handle points associated to narcolepsy, psychiatry, ache administration, and oncology.

• Income (TTM): $3.33 billion
• Web Revenue (TTM): $876.05 million
• Market Cap: $17.93 billion
• 1-Yr Trailing Whole Return: 10.56%
• Change: Nasdaq

Focusing totally on small molecule medicine to be used in oncology, Incyte is a biopharmaceutical firm answerable for discovering, growing, and advertising drug therapies. The corporate is finest identified for its drug Jakafi, a remedy for myelofibrosis.

• Income (TTM): $2.39 billion
• Web Revenue (TTM): -$1.32 billion
• Market Cap: $810.16 million
• 1-Yr Trailing Whole Return: -95.25%
• Change: Nasdaq

Novavax is headquartered in Gaithersburg, MD, and was based in 1987. It’s a biotech firm solely targeted on growing vaccines to battle infectious illnesses whereas championing entry to life-saving vaccines worldwide.

• Income (TTM): $2.37 billion
• Web Revenue (TTM): $1.14 billion
• Market Cap: $3.34 billion
• 1-Yr Trailing Whole Return: -53.32%
• Change: Nasdaq

Vir Biotechnology was based in 2017 and is headquartered in San Francisco, CA. It focuses on treating infectious illnesses utilizing newly-developed applied sciences to determine weaknesses in pathogens and exploit them.

BioMarin Pharmaceutical Inc. (BRMN)

• Income (TTM): $2.01 billion
• Web Revenue (TTM): $83.91 million
• Market Cap: $19.81 billion
• 1-Yr Trailing Whole Return: 23.28%
• Change: Nasdaq

Based in 1977, BioMarin is headquartered in San Rafael, CA. It has 3,000 workers and focuses on growing remedies for genetic problems reminiscent of phenylketonuria (PKU), CLN2 illness, MPS (IVA, VA, I), and achondroplasia.